Media coverage
27
Media coverage
Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Tucson.com Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Business Wire Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Morningstar.com Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet TMC Net Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet StocksNewsFeed.com Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet WorldNews.se Country/Territory Sweden Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Maryville Daily Times Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title CALVIRI, INC. : Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet MarketScreener.com Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License... Media name/outlet ADVFN Deutschland Country/Territory Germany Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet TD Ameritrade Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Customer Zone 360.com Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Drug Genius Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet PICANTE Today Country/Territory Romania Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet DigitalMunition Country/Territory France Date 10/13/20 Persons Stephen Johnston Title admin wrote a new post, Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet DigitalMunition Country/Territory France Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Jotup Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Acrofan Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet CIT Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Intellasia.net Country/Territory Viet Nam Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet OA Online Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Galveston County Daily News Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Elk Valley Times Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Tullahoma News Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Manchester Times Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Yuma Sun Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Herald Chronicle Country/Territory United States Date 10/13/20 Persons Stephen Johnston Title Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities Media name/outlet Digital Media Net Country/Territory United States Date 10/13/20 Persons Stephen Johnston